- Home
- GROV vs SNTI Comparison
GROV vs SNTI Comparison
Compare GROV & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GROV
- SNTI
- Stock Information
- Founded
- GROV 2016
- SNTI 2016
- Country
- GROV United States
- SNTI United States
- Employees
- GROV N/A
- SNTI N/A
- Industry
- GROV Package Goods/Cosmetics
- SNTI Biotechnology: Pharmaceutical Preparations
- Sector
- GROV Consumer Discretionary
- SNTI Health Care
- Exchange
- GROV Nasdaq
- SNTI Nasdaq
- Market Cap
- GROV 55.0M
- SNTI 53.6M
- IPO Year
- GROV N/A
- SNTI N/A
- Fundamental
- Price
- GROV $1.36
- SNTI $2.05
- Analyst Decision
- GROV Buy
- SNTI Strong Buy
- Analyst Count
- GROV 2
- SNTI 4
- Target Price
- GROV $1.60
- SNTI $8.75
- AVG Volume (30 Days)
- GROV 89.6K
- SNTI 98.5K
- Earning Date
- GROV 11-13-2025
- SNTI 11-13-2025
- Dividend Yield
- GROV N/A
- SNTI N/A
- EPS Growth
- GROV N/A
- SNTI N/A
- EPS
- GROV N/A
- SNTI N/A
- Revenue
- GROV $180,808,000.00
- SNTI N/A
- Revenue This Year
- GROV N/A
- SNTI N/A
- Revenue Next Year
- GROV $11.10
- SNTI $150.00
- P/E Ratio
- GROV N/A
- SNTI N/A
- Revenue Growth
- GROV N/A
- SNTI N/A
- 52 Week Low
- GROV $1.02
- SNTI $1.26
- 52 Week High
- GROV $1.95
- SNTI $16.94
- Technical
- Relative Strength Index (RSI)
- GROV 47.14
- SNTI 57.75
- Support Level
- GROV $1.29
- SNTI $1.44
- Resistance Level
- GROV $1.40
- SNTI $2.16
- Average True Range (ATR)
- GROV 0.08
- SNTI 0.18
- MACD
- GROV 0.00
- SNTI 0.02
- Stochastic Oscillator
- GROV 43.50
- SNTI 88.19
About GROV Grove Collaborative Holdings Inc.
Grove Collaborative Holdings Inc is engaged in providing consumer products. It offers Cleaning accessories, Home and Pantry, Personal care products, Pets supplements and Other products. It is a sustainability oriented consumer products generator. It use connection with consumers to create and curate authentic, disruptive brands and products. Company builds natural products that perform as well as, many consumer packaged goods (CPG) brands (both conventional and natural), while being healthier for consumers and the planet.
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.